Partner/Owner since 2003
Founder since 2003
Representative before the EPO

Employment test 11 - 50 employees
Company dna isenbruck bosl horschler llp
operating since 2003
Headquarter in Mannheim and 3 offices
active in Legal Services and IP Consulting

Raphael Bösl has worked on the following 189 EPO patent applications which have been published in the last five years:

EP11734694

SOLUTION PREPARATION CONTAINING STABILIZED ANTIBODY

IPC classification:
A61K 9/08, A61K 9/19, A61K 39/00, A61K 47/18, A61K 47/26
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP11750823

ANTIBODY CONSTANT REGION VARIANT

IPC classification:
A61K 38/16, A61K 39/395, A61P 37/00, C07K 16/28, C12N 15/09
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP11753831

METHODS AND DEVICES FOR LESS INVASIVE GLENOID REPLACEMENT

IPC classification:
A61F 2/40
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP11005110

Cathepsin-binding compounds bound to a nanodevice and their diagnostic and therapeutic use

IPC classification:
A61K 9/127, A61K 47/48, A61K 49/00, A61K 49/18, A61P 29/00, A61P 35/00, C07D 405/12, C07K 7/02
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP11845786

CYTOTOXICITY-INDUCING THERAPEUTIC AGENT

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/28, C07K 16/30, C07K 16/46, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP10839561

POLYPEPTIDE MODIFICATION METHOD FOR PURIFYING POLYPEPTIDE MULTIMERS

IPC classification:
A61K 39/395, C07K 1/22, C07K 14/735, C07K 16/00, C07K 16/28, C07K 16/30, C07K 16/36, C07K 16/46, C07K 19/00, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/00, C12N 15/09
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP10839538

GENE Dro1 CONTROLLING DEEP-ROOTED CHARACTERISTICS OF PLANT AND UTILIZATION OF SAME

IPC classification:
A01H 5/00, C07K 14/415, C12N 5/00, C12N 15/82, C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP11850640

TRYPSIN-LIKE SERINE PROTEASE INHIBITORS, THEIR PREPARATION AND USE AS SELECTIVE INHIBITORS OF THE CLOTTING FACTORS IIA AND XA

IPC classification:
A61K 38/05, A61P 7/06, A61P 9/00, C07D 205/04, C07D 207/16, C07D 211/60, C07D 295/192, C07D 401/12, C07D 403/12, C07D 405/12, C07K 5/06, C07K 5/072, C07K 5/078
Applicant:
The Medicines Company (Leipzig) GmbH
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP11786748

ANTITUMOR T CELL RESPONSE ENHANCER

IPC classification:
A61K 31/7068, A61K 39/395, A61P 35/00, A61P 43/00, C07K 16/28
Applicant:
Hokkaido University
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP10838296

METHODS AND COMPOSITIONS FOR TREATING INFLAMMATION OF SKIN

IPC classification:
A61K 31/135, A61K 31/335, A61K 31/4402, A61K 31/55, A61K 45/06, A61P 29/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12719479

CONSTRUCTS AND METHODS FOR GENERATING INDUCED PLURI POTENT STEM ( IPS) CELLS

IPC classification:
C12N 5/07, C12N 5/10, C12N 15/861
Applicant:
University of Utah Research Foundation - Technology and Venture Commercialization (TVC)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12749985

SUPERHYDROPHOBIC AND OLEOPHOBIC COATINGS WITH LOW VOC BINDER SYSTEMS

IPC classification:
B23B 5/02, B23B 27/04, B23B 27/12, C09D 175/04, C09K 3/18
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12005814

Fluid exchange catheter and process for unblocking a fluid exchange catheter

IPC classification:
A61M 25/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION REFUSED
EP12005830

Fluid exchange catheter

IPC classification:
A61M 25/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION REFUSED
EP12721111

PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY

IPC classification:
A61K 31/4965, A61K 31/497, A61P 7/06
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12722013

PYRUVATE KINASE ACTIVATORS FOR USE IN THERAPY

IPC classification:
A61K 31/4965, A61K 31/497, A61P 7/06
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12722012

PYRUVATE KINASE ACTIVATORS FOR USE FOR INCREASING LIFETIME OF THE RED BLOOD CELLS AND TREATING ANEMIA

IPC classification:
A61K 31/4704, A61K 31/495, A61K 31/496, A61K 31/5025, A61K 31/551, A61K 31/635, A61P 7/06, A61P 43/00
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12724632

DISPENSER WITH FILTER DEVICE

IPC classification:
B01D 35/027, G01N 1/31, G01N 35/10
Applicant:
Ventana Medical Systems, Inc.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP11008057

Process line for the production of freeze-dried particles

IPC classification:
F26B 5/06
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12799802

COMPOUNDS, THEIR PHARMACEUTICAL COMPOSITIONS AND THEIR USES AS IDH1 MUTANTS INHIBITORS FOR TREATING CANCERS

IPC classification:
A61K 31/496, A61P 35/00, C07D 217/26, C07D 413/04, C07D 491/052, C07D 519/00
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP11008109

Rotary drum for use in a vacuum freeze-dryer

IPC classification:
F26B 5/06
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11008058

Rotary drum freeze-dryer

IPC classification:
F26B 5/06
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12730388

CATHEPSIN-BINDING COMPOUNDS BOUND TO A CARRIER AND THEIR DIAGNOSTIC USE

IPC classification:
A61K 9/127, A61K 47/48, A61K 49/00, A61K 49/18, A61P 29/00, A61P 35/00, C07D 405/12, C07K 7/02
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP10838320

METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRIGEMINAL AUTONOMIC CEPHALGIAS, MIGRAINE, AND VASCULAR CONDITIONS

IPC classification:
A61K 31/192, A61K 31/196, A61K 31/60, A61K 45/06, A61P 29/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12812054

NMR METHODS FOR MONITORING BLOOD CLOT FORMATION

IPC classification:
C12Q 1/56
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12741236

IMPROVED METHODS AND COMPOSITIONS FOR MODULATION OF OLFML3 MEDIATED ANGIOGENESIS

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/18
Applicant:
Research Development Foundation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12820719

TREATMENT OF HEART FAILURE AND RELATED CONDITIONS

IPC classification:
A61K 38/18, A61P 9/00, C07K 14/495
Applicant:
Tufts Medical Center, Inc.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12777328

PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME

IPC classification:
A61K 31/40, C07C 251/86, C07D 487/04, C07D 519/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP12772695

METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE OLANZAPINE POOR RESPONSE PREDICTOR GENETIC SIGNATURE

IPC classification:
A61K 31/495, A61K 31/517, A61K 31/5415, A61K 31/5513, A61K 31/554, A61P 25/18, C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12826213

NOVEL ANTI-DDR1 ANTIBODY HAVING ANTI-TUMOR ACTIVITY

IPC classification:
A61K 39/395, A61P 35/00, C07K 16/30, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, C12P 21/08
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12833431

NMR METHODS FOR ENDOTOXIN ANALYSIS

IPC classification:
G01V 3/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12830083

METHODS FOR TAGGING DNA-ENCODED LIBRARIES

IPC classification:
C40B 50/14, C40B 50/16
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12748701

SLIDE TRANSFER DEVICE

IPC classification:
B01L 9/00, G02B 21/34
Applicant:
Ventana Medical Systems, Inc.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12753456

IMAGING SYSTEMS, CASSETTES, AND METHODS OF USING THE SAME

IPC classification:
G01N 35/04, G02B 21/24, G02B 21/34
Applicant:
Ventana Medical Systems, Inc.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12769743

ANTI THIRD PARTY CENTRAL MEMORY T CELLS, METHODS OF PRODUCING SAME AND USE OF SAME IN TRANSPLANTATION AND DISEASE TREATMENT

IPC classification:
A61K 39/00
Applicant:
Yeda Research and Development Co. Ltd.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12758868

ANTI-HER2 VACCINE BASED UPON AAV DERIVED MULTIMERIC STRUCTURES

IPC classification:
A61K 39/00, C07K 14/005, C07K 14/71
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12835716

USE OF HEMOPEXIN TO SEQUESTER HEMOGLOBIN

IPC classification:
C12N 5/07
Applicant:
The General Hospital Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12769023

HEATING DEVICE FOR ROTARY DRUM FREEZE-DRYER

IPC classification:
F26B 3/30, F26B 5/06
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP12769022

ROTARY DRUM FOR USE IN A VACUUM FREEZE-DRYER

IPC classification:
F26B 5/06
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP12769021

PROCESS LINE FOR THE PRODUCTION OF FREEZE-DRIED PARTICLES

IPC classification:
A61K 9/16, F26B 5/06
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP12769026

PROCESS LINE FOR THE PRODUCTION OF FREEZE-DRIED PARTICLES

IPC classification:
A61K 9/16, F26B 5/06
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP12843467

DEVICE AND METHOD FOR SUSTAINED RELEASE OF THERAPEUTIC AGENT

IPC classification:
A61K 9/16, A61K 9/20, A61P 3/00, A61P 9/00, A61P 29/00
Applicant:
The Board of Regents of the University of Texas System
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12844389

CANCER STEM CELL-SPECIFIC MOLECULE

IPC classification:
A61K 39/39, A61K 39/395, C12Q 1/68, G01N 33/15, G01N 33/50, G01N 33/574
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12829642

CANCER STEM CELL ISOLATION

IPC classification:
A61K 31/4745, A61K 31/513, A61K 31/7088, A61K 39/395, A61K 48/00, A61P 35/00, A61P 35/02, A61P 35/04, C07K 16/30, C12N 5/095, C12N 15/09, C12N 15/113, C12Q 1/02, C12Q 1/04, G01N 33/15, G01N 33/53, G01N 33/574
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP11830729

CANCER STEM CELL MASS AND PROCESS FOR PRODUCTION THEREOF

IPC classification:
A61K 45/00, A61P 35/00, C12N 5/00, C12N 5/071, C12N 5/095, C12Q 1/02, G01N 33/15, G01N 33/50
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP10839531

METHOD FOR SEARCHING AND SCREENING FOR TARGET OF ANTI-CANCER AGENT USING NON-HUMAN ANIMAL MODEL HAVING NOG ESTABLISHED CANCER CELL LINE TRANSPLANTED THEREIN

IPC classification:
A01K 67/027, C12N 5/09, C12N 5/10, C12Q 1/02, C12Q 1/68, G01N 33/15, G01N 33/50, G01N 33/68
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12846665

ANTIGEN-BINDING MOLECULE HAVING REGULATED CONJUGATION BETWEEN HEAVY-CHAIN AND LIGHT-CHAIN

IPC classification:
A61K 39/395, C07K 16/46, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/09, C12P 21/02, C12P 21/08
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12853451

ARTIFICIAL KNEE JOINT

IPC classification:
A61F 2/38
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12857248

COMPOSITION AND COATING FOR SUPERHYDROPHOBIC PERFORMANCE

IPC classification:
C09D 5/00, C09K 3/18
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13736185

TRYPTOLINE DERIVATIVES HAVING KINASE INHIBITORY ACTIVITY AND USES THEREOF

IPC classification:
A61K 31/437
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13735755

BENZHYDROL-PYRAZOLE DERIVATIVES HAVING KINASE INHIBITORY ACTIVITY AND USES THEREOF

IPC classification:
A61K 31/415
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13736137

METHOD FOR MODULATING PLANT ROOT ARCHITECTURE

IPC classification:
A01H 3/04, A01P 5/00, A01P 21/00, C12N 15/29
Applicant:
North Carolina State University - Office of Technology Transfer
Applicant:
Australian National University
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12800001

THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHODS OF USE

IPC classification:
A61K 31/44, A61K 31/496, A61P 35/00, C07D 213/85, C07D 401/04, C07D 401/12, C07D 401/14, C07D 405/12, C07D 405/14, C07D 409/14, C07D 413/14, C07D 417/14, C07D 471/04, C07D 487/04, C07D 498/04
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13738187

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

IPC classification:
A61K 31/16, A61K 31/357, A61K 31/381, A61K 31/40, A61K 31/415, A61K 31/4164, A61K 31/4192, A61K 31/426, A61K 31/435, A61K 31/495, A61P 35/00, C07C 237/22, C07C 271/22, C07C 271/44
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP14464003

Stable pharmaceutical composition comprising amorphous rosuvastatin calcium

IPC classification:
A61K 9/20, A61K 31/505
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12769025

A PROCESS LINE FOR THE PRODUCTION OF FREEZE-DRIED PARTICLES

IPC classification:
F26B 5/06
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP13738319

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

IPC classification:
A61K 31/16, A61K 31/38, A61K 31/40, A61K 31/41, A61K 31/495, A61P 35/00, C07C 237/22
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13746177

HYDROPHOBIC SURFACES ON INJECTION MOLDED OR SHAPED ARTICLES

IPC classification:
B32B 3/02
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12861199

PEPTIDE-COMPOUND CYCLIZATION METHOD

IPC classification:
C07K 1/08, C07K 1/113, C12N 15/09, C12P 21/02, C40B 40/10
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13733752

THERAPEUTICALLY ACTIVE COMPOUNDS AND THEIR METHODS OF USE

IPC classification:
A61K 31/53, A61P 35/00, C07D 251/18, C07D 251/26
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Agent:
Jones Day
Status:
EXAMINATION IN PROGRESS
EP12814155

STABLE PROTEIN-CONTAINING PREPARATION CONTAINING ARGININAMIDE OR ANALOGOUS COMPOUND THEREOF

IPC classification:
A61K 9/08, A61K 39/395, A61K 47/12, A61K 47/18, A61K 47/22, C07K 16/28, C12N 15/09, C12P 21/08
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13751876

CONTAINERS FOR AGITATION OF LIQUID SAMPLES AND METHODS OF USE THEREOF

IPC classification:
B65D 90/02
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP10838322

METHODS AND COMPOSITIONS FOR STABLE LIQUID DRUG FORMULATIONS

IPC classification:
A61K 9/00, A61K 9/16, A61K 9/48, A61K 9/50, A61K 9/64, A61K 31/192, A61K 31/4468
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12873112

METHOD FOR DISSOLVING FLAVONOID COMPOUND, CARBON GLYCOSIDE COMPOUND, OR STILBENE COMPOUND AND METHOD FOR PREPARING INJECTION OR POWDER FOR INJECTION

IPC classification:
A61K 9/08, A61K 9/19, A61K 47/10, A61K 47/22, A61P 1/16, A61P 5/30, A61P 7/02, A61P 9/00, A61P 9/06, A61P 9/10, A61P 29/00, A61P 31/04, A61P 31/12, A61P 35/00, A61P 39/06
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP12873232

APPLICATION OF GASTRODIN AS SOLUBILIZER AND METHOD FOR PREPARING INJECTION OR POWDER FOR INJECTION

IPC classification:
A61K 9/08, A61K 9/14, A61K 47/22
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP13822828

CRYSTAL FORM OF CABAZITAXEL AND PREPARATION METHOD THEREOF

IPC classification:
A61K 31/337, A61P 35/00, C07D 305/14
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13779063

COMPOSITIONS AND METHODS FOR DETECTION OF CANDIDA SPECIES

IPC classification:
C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12874920

METHOD FOR PREPARING 5,6,4'-TRIHYDROXYFLAVONE-7-0-D-GLUCURONIC ACID

IPC classification:
C07H 17/07
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP13781905

COMPOSITIONS AND METHODS RELATED TO ANTIBODIES THAT NEUTRALIZE COAGULASE ACTIVITY DURING STAPHYLOCOCCUS AUREUS DISEASE

IPC classification:
A61K 38/17, A61K 39/395, A61P 31/00, A61P 31/04
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13781062

QUINAZOLINEDIONE DERIVATIVE

IPC classification:
A61K 31/517, A61K 31/5377, A61P 19/04, A61P 29/00, A61P 35/00, A61P 35/04, A61P 43/00, C07D 239/96, C07D 401/06, C07D 403/06, C07D 405/04, C07D 405/12, C07D 487/04
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP13720688

METHOD FOR DEVELOPING NATURAL KILLER CELLS FROM STEM CELLS

IPC classification:
A61K 35/14, A61K 35/54, C12N 5/0735, C12N 5/0783
Applicant:
University of Minnesota
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13782636

BENZAMIDE DERIVATIVE

IPC classification:
A61K 31/166, A61K 31/40, A61K 31/445, A61K 31/495, A61K 31/496, A61P 19/04, A61P 29/00, A61P 35/00, A61P 35/02, A61P 43/00, C07C 211/56, C07C 317/32, C07C 317/34, C07C 323/42, C07C 323/46, C07D 205/04, C07D 207/09, C07D 207/12, C07D 207/14, C07D 211/26
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP13781494

STAPHYLOCOCCAL COAGULASE ANTIGENS AND METHODS OF THEIR USE

IPC classification:
A61K 38/43, A61P 31/04, C07K 19/00, C12N 15/62, C12N 15/63
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP11708743

INHIBITORS OF GLYCOGEN SYNTHASE KINASE 3 FOR USE IN THERAPEUTIC METHODS AND SCREENING METHOD RELATING THERETO

IPC classification:
A61K 31/4015, A61K 31/404, A61K 31/519, A61P 11/00
Applicant:
Helmholtz Zentrum München - Deutsches Forschungszentrum für Gesundheit und Umwelt GmbH
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14189654

Methods of organ regeneration

IPC classification:
C12N 5/07
Applicant:
The General Hospital Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13785315

BIOAVAILABILITY OF ORAL METHYLNALTREXONE INCREASES WITH A PHOSPHATIDYLCHOLINE-BASED FORMULATION

IPC classification:
A01N 43/42, A61K 31/44
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13807865

METHODS COMPOSITIONS RELATED TO THE SMCHD1 GENE

IPC classification:
C12N 15/12, C12Q 1/68
Applicant:
Leiden University Medical Center (Leids Universitair Medisch Centrum (LUMC) - Academisch Ziekenhuis Leiden)
Applicant:
University of Rochester Medical Center
Applicant:
University of Washington CoMotion
Applicant:
Fred Hutchinson Cancer Research Center
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13810699

PORTABLE DEVICE FOR NMR BASED ANALYSIS OF RHEOLOGICAL CHANGES IN LIQUID SAMPLES

IPC classification:
G01V 3/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12881905

METHOD FOR PREPARING HIGH PURITY SCUTELLARIN AGLYCONE

IPC classification:
C07D 311/30
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14177558

Microwave range

IPC classification:
H05B 6/64
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP13816635

DNA-ENCODED LIBRARIES HAVING ENCODING OLIGONUCLEOTIDE LINKAGES NOT READABLE BY POLYMERASES

IPC classification:
C40B 40/06
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP14177550

Ice bin and method of transferring ice using the same

IPC classification:
F25C 5/04, F25C 5/18
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14177557

Refrigerator with a configurable space

IPC classification:
F25D 11/02, F25D 29/00
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14177553

Ice bin and method of crushing ice using the same

IPC classification:
F25C 5/18
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13001977

TREATMENT OF ISCHEMIA USING STEM CELLS

IPC classification:
A61K 9/00, A61K 35/44, A61K 35/50, A61P 9/10, C12N 5/00, C12N 5/074
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13740246

FLUID EXCHANGE CATHETER AND PROCESS FOR UNBLOCKING A FLUID EXCHANGE CATHETER

IPC classification:
A61M 25/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP13829748

EXOSOME-BASED THERAPEUTICS AGAINST NEURODEGENERATIVE DISORDERS

IPC classification:
A61K 9/127, C12N 15/88
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14832164

PHARMACEUTICAL PREPARATION COMPRISING AMINOPYRAZOLE DERIVATIVE

IPC classification:
A61K 9/06, A61K 9/14, A61K 9/16, A61K 9/20, A61K 9/48, A61K 31/4184, A61K 47/12, A61K 47/20, A61K 47/32, A61K 47/36, A61K 47/38, A61P 35/00, A61P 43/00
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14177219

Cooling apparatus for refrigerator and control method thereof

IPC classification:
F25B 5/00, F25B 47/02, F25D 11/02
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14177014

Refrigerator for preventing and/or reducing condensation and method for controlling same

IPC classification:
F25D 17/06, F25D 21/04
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14177561

Refrigerator

IPC classification:
F25D 23/04, F25D 25/02
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13773563

ATTENUATED CHIKUNGUNYA VIRUS

IPC classification:
A61K 39/12, C07K 14/005
Applicant:
Research Development Foundation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP13842962

FGFR3 FUSION GENE AND PHARMACEUTICAL DRUG TARGETING SAME

IPC classification:
A61K 31/4184, A61K 31/4439, A61K 31/454, A61K 31/496, A61K 31/5377, A61K 31/713, A61K 45/00, A61K 47/42, A61P 35/00, C07K 14/46, C07K 14/71, C07K 16/18, C07K 16/30, C07K 19/00, C12N 1/15, C12N 1/19, C12N 1/21, C12N 5/10, C12N 15/02, C12N 15/09
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP13842222

METHOD FOR EVALUATING BLOOD COAGULATION REACTION

IPC classification:
G01N 33/86
Applicant:
Nara Medical University
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13846787

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

IPC classification:
A61K 31/17, A61K 31/18
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP11826890

METHOD FOR PRODUCING CRUCIFEROUS PLANT RESISTANT TO CLUBROOT

IPC classification:
A01H 1/00, A01H 5/00, C12N 5/10, C12N 15/29, C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION WITHDRAWN
EP13849295

SYNERGISTIC COMBINATION OF IMMUNOLOGIC INHIBITORS FOR THE TREATMENT OF CANCER

IPC classification:
A61K 31/41, A61K 31/4245
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13801915

BARCODING NUCLEIC ACIDS

IPC classification:
C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP13849803

PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME

IPC classification:
C07D 487/04
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13848995

PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME

IPC classification:
A61K 31/5025
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13795929

THERAPEUTIC COMPOUNDS AND COMPOSITIONS AND THEIR USE AS PKM2 MODULATORS

IPC classification:
A61K 31/397, A61K 31/4709, A61P 7/00, A61P 35/00, C07D 205/04, C07D 401/12, C07D 401/14, C07D 405/12
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13850898

ANTIBIOTIC METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS

IPC classification:
A01N 37/18, A01N 43/16, A01N 63/00, A61K 31/497
Applicant:
University of Chicago
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13852797

VIBRATION DAMPING MATERIAL

IPC classification:
C08K 3/04, C08K 5/14, C08L 33/04, C08L 63/00, C08L 93/00, C09K 3/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP13857585

COMPOUNDS AND THEIR METHODS OF USE

IPC classification:
A61K 31/4245, A61K 31/433, A61P 35/00, C07D 413/08, C07D 413/14, C07D 417/08, C07D 417/14
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13808311

GLUTAMINASE INHIBITORS AND METHOD OF USE

IPC classification:
A61K 31/433, A61P 35/00, A61P 37/00, C07D 285/12
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP14177214

Absorption refrigeration system

IPC classification:
F25B 15/02, F25B 15/06, F25B 29/00
Applicant:
Dongbu Daewoo Electronics Corporation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13860819

METHODS FOR MONITORING TIGHT CLOT FORMATION

IPC classification:
C12Q 1/56, G01N 24/08
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP13865627

COMPOSITIONS AND METHODS FOR THE IDENTIFICATION AND ISOLATION OF CELL-MEMBRANE PROTEIN SPECIFIC BINDING MOIETIES

IPC classification:
C04B 20/04, C12N 1/00, C40B 30/04
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP12731990

METHOD FOR IMPROVING PHYSICAL PROPERTIES OF ANTIBODY

IPC classification:
A61K 39/395, A61P 37/06, C07K 16/36, C12P 21/02, C12P 21/08, C12Q 1/02, G01N 33/53
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP13898642

FIVE LEVEL INVERTER

IPC classification:
H02M 7/48
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14749616

AUTOMATIC ANALYSIS DEVICE

IPC classification:
G01N 21/76, G01N 27/28, G01N 27/416, G01N 35/08
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14757218

METHODS FOR THE PRODUCTION OF LIBRARIES FOR DIRECTED EVOLUTION

IPC classification:
C40B 10/00, C40B 40/00, C40B 40/06, C40B 50/06
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14754094

METHODS AND DEVICES FOR SKIN TIGHTENING

IPC classification:
A61F 13/02
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14764384

METHODS AND COMPOSITIONS FOR BACTERIA INFECTIONS

IPC classification:
A61P 31/04
Applicant:
University of Chicago
Applicant:
Board of Trustees of the University of Illinois
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14775449

COMPOSITIONS AND METHODS FOR DETECTING AND DETERMINING A PROGNOSIS FOR PROSTATE CANCER

IPC classification:
C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14774108

GRAFTED POLYETHYLENE

IPC classification:
C08F 4/28, C08F 255/02, C08F 290/06
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14765650

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

IPC classification:
A61K 31/18, A61K 31/428, A61K 31/473, A61K 31/4738, A61K 31/495, A61P 7/06, A61P 35/02, C07D 401/10, C07D 401/12, C07D 413/10, C07D 413/12, C07D 417/10, C07D 417/12
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14765803

NANOLAMINATE COATINGS

IPC classification:
C25D 5/10
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14763369

METHODS AND COMPOSITIONS FOR GENERATING STABLE TRANSFECTED CELLS

IPC classification:
C12N 5/10
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14762282

NICKEL CHROMIUM NANOLAMINATE COATING HAVING HIGH HARDNESS

IPC classification:
C25D 5/14
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP13001539

Modified antibodies with enhanced biological activities

IPC classification:
C07K 16/28, C07K 16/46, C12N 15/09, C12P 21/08
Applicant:
Teijin Pharma Limited
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13159160

Antibodies to the chemokine receptor XCR1

IPC classification:
C07K 16/28
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14794420

COMPOSITIONS AND METHODS FOR PROMOTING NITRIC OXIDE PRODUCTION THROUGH AN ORAL DELIVERY SYSTEM

IPC classification:
A61K 35/74
Applicant:
The Board of Regents of the University of Texas System
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14791060

MICROCLOSURES AND RELATED METHODS FOR SKIN TREATMENT

IPC classification:
A61F 13/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14882792

CENTRALIZED MPPT EXITING AND SWITCHING METHOD AND APPLICATION THEREOF

IPC classification:
H02J 3/38
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION PUBLISHED
EP14768716

IDENTIFICATION AND USE OF CIRCULATING NUCLEIC ACID TUMOR MARKERS

IPC classification:
C12Q 1/68
Applicant:
The Board of Trustees of the Leland Stanford Junior University
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14794056

HEART VALVE ASSISTIVE PROSTHESIS

IPC classification:
A61F 2/24
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP11756868

PLUNGER AND METHODS OF PRODUCING HYDROPHOBIC SURFACES

IPC classification:
C09D 5/00, C09D 175/04, E03C 1/308
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP14819418

PYRROLOQUINOLINE QUINONE LITHIUM SALT CRYSTAL AND PREPARATION METHOD AND APPLICATION THEREOF

IPC classification:
A61K 31/4745, A61P 25/28, C07D 471/04
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14765733

ELECTRODEPOSITED COMPOSITIONS AND NANOLAMINATED ALLOYS FOR ARTICLES PREPARED BY ADDITIVE MANUFACTURING PROCESSES

IPC classification:
C25D 3/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14811138

METHOD FOR PREDICTING POST-THERAPY PROGNOSIS OF RELAPSING-REMITTING MULTIPLE SCLEROSIS (RRMS) PATIENT, AND METHOD FOR DETERMINING APPLICABILITY OF NOVEL THERAPY

IPC classification:
A61K 39/395, A61K 45/00, A61P 25/00, C12Q 1/06, G01N 33/50
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP15003342

ELECTRODEPOSITED NANOLAMINATE COATINGS AND CLADDINGS FOR CORROSION PROTECTION

IPC classification:
C25D 5/10, C25D 5/14, C25D 5/18, C25D 5/20, C25D 15/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14822346

AN OPTICAL ELEMENT HAVING TWO PHASE MASKS

IPC classification:
G01J 5/08, G02B 1/00, G02B 5/00, G02B 27/00, G06K 7/14, G06K 19/06
Applicant:
Ramot at Tel-Aviv University Ltd.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14832195

NANOCHANNELED DEVICE WITH ELECTRODES AND RELATED METHODS

IPC classification:
A61K 9/48, A61M 37/00
Applicant:
The Board of Regents of the University of Texas System
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP11810506

MATERIAL AND PROCESS FOR ELECTROCHEMICAL DEPOSITION OF NANOLAMINATED BRASS ALLOYS

IPC classification:
C23C 18/48, C25D 1/00, C25D 3/56, C25D 3/58, C25D 5/10, C25D 5/18, C25D 5/54, C25D 5/56
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14836861

DEVICE AND METHOD FOR SUSTAINED RELEASE OF LOW WATER SOLUBILITY THERAPEUTIC AGENT IN SOLUBILIZER

IPC classification:
A61K 9/52, A61M 37/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14849352

METHOD FOR PRODUCING ANTIGEN-BINDING MOLECULE USING MODIFIED HELPER PHAGE

IPC classification:
C12N 7/00, C12N 15/09, C12P 21/08
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP11738902

THERAPEUTICALLY ACTIVE COMPOSITIONS AND THEIR METHOD OF USE

IPC classification:
A61K 31/16, A61K 31/18, A61K 31/357, A61K 31/381, A61K 31/40, A61K 31/415, A61K 31/4164, A61K 31/4192, A61K 31/426, A61K 31/435, A61K 31/495, A61P 43/00, C07C 237/22, C07C 271/22, C07C 271/44
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP11811286

THERAPEUTIC COMPOUNDS AND COMPOSITIONS

IPC classification:
A61K 31/496, A61P 35/00
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP10796233

THERAPEUTICALLY ACTIVE COMPOUNDS FOR USE IN THE TREATMENT OF CANCER CHARACTERIZED AS HAVING AN IDH MUTATION

IPC classification:
A61K 31/495, A61K 31/496, A61K 31/506, A61K 31/551, A61P 35/00, C07D 243/08, C07D 405/12
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The patent has been granted
EP14839001

ENGINEERED PRIMATE CYSTINE/CYSTEINE DEGRADING ENZYMES AS ANTINEOGENIC AGENTS

IPC classification:
C12N 9/88
Applicant:
The Board of Regents of the University of Texas System
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14841459

NMR SENSOR FOR RAPID, NON-INVASIVE DETERMINATION OF HYDRATION STATE OR VASCULAR VOLUME OF A SUBJECT

IPC classification:
A61B 5/05, G01N 24/08
Applicant:
Massachusetts Institute of Technology (MIT) Inc.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP11763425

METHODS OF IDENTIFYING A CANDIDATE COMPOUND

IPC classification:
C12Q 1/02
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP10774412

METHODS AND COMPOSITIONS FOR THE TREATMENT OF PSYCHOTIC DISORDERS THROUGH THE IDENTIFICATION OF THE SULT4A1-1 HAPLOTYPE

IPC classification:
A61K 31/496, A61K 31/519, A61K 31/5415, A61K 31/55, A61K 31/5513, A61P 25/18, C12Q 1/68
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP14847194

FLEXIBLE SUPERHYDROPHOBIC AND/OR OLEOPHOBIC POLYURETHANE COATINGS

IPC classification:
C08G 18/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14845187

UNIVERSAL RECHARGEABLE BATTERY CONSTITUTED BY EMPLOYING LITHIUM-ION BATTERY AND CONTROL METHOD

IPC classification:
H01M 10/42, H02J 7/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP14847022

IDENTIFICATION OF STRUCTURALLY SIMILAR SMALL MOLECULES THAT ENHANCE THERAPEUTIC EXON SKIPPING

IPC classification:
C12Q 1/68
Applicant:
The Regents of the University of California
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
GRANT OF PATENT INTENDED
EP16164863

FLUID EXCHANGE CATHETER AND PROCESS FOR UNBLOCKING A FLUID EXCHANGE CATHETER

IPC classification:
A61M 25/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14855498

QUINAZOLINONE AND ISOQUINOLINONE DERIVATIVE

IPC classification:
A61K 31/472, A61K 31/517, A61K 31/519, A61K 31/5377, A61K 31/553, A61P 11/00, A61P 29/00, A61P 35/00, A61P 35/04, C07D 217/24, C07D 239/91, C07D 239/94, C07D 401/06, C07D 401/12, C07D 403/06
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP16152308

METHODS AND COMPOSITIONS FOR CELL-PROLIFERATION-RELATED DISORDERS

IPC classification:
A61K 31/225, C12Q 1/68
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14789753

CORROSION INHIBITING COMPOSITIONS AND METHODS

IPC classification:
C23F 11/08, C23F 11/173, C23F 11/18
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP16163214

PHARMACEUTICAL COMPOSITIONS AND MEDICAL USES OF ENGINEERED HUMAN ARGINASES

IPC classification:
A61K 38/48, A61P 35/00, C07K 19/00, C12N 9/50, C12N 15/57, C12N 15/62
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP11780713

SCREENING METHOD FOR SUBSTANCE HAVING HEMOCYTE MATURATION ACCELERATION ACTION

IPC classification:
C12N 5/078, G01N 33/50, G01N 33/80
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Applicant:
Kumamoto University
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11007657

Mutant lactate oxidase with increased stability and product, methods and uses involving the same

IPC classification:
A61B 5/1486, C12N 9/02
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14860720

GENETIC MARKERS OF ANTIPSYCHOTIC RESPONSE

IPC classification:
A61P 25/18
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP16162975

CRYSTAL FORM OF CABAZITAXEL AND PREPARATION METHOD THEREOF

IPC classification:
A61K 31/337, A61P 35/00, C07D 305/14
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION IN PROGRESS
EP14861246

DISACCHARIDE INTERMEDIATE AND SYNTHESIS METHOD THEREOF

IPC classification:
C07H 1/00, C07H 3/10, C07H 13/08
Applicant:
Zhejiang Hisun Pharmaceutical Co. Ltd.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP12703422

ENGINEERED IMMUNOGLOBULIN FC POLYPEPTIDES

IPC classification:
C07K 16/28, C07K 16/32
Applicant:
Research Development Foundation
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP14864650

GRAFTED POLYMER COMPOSITIONS

IPC classification:
C08F 290/00, C08F 299/00, C08G 81/00, C08J 3/24, C08L 101/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP11811257

BICYCLIC PKM2 ACTIVATORS

IPC classification:
A61K 31/536, A61K 31/538, A61P 35/00, C07D 265/18, C07D 265/36, C07D 413/12
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP11737505

METHOD OF PRODUCING CYCLOHEXASILANE COMPOUNDS

IPC classification:
C01B 33/04, C07F 7/02, C07F 9/54
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP11808773

NOVEL N-(4-(AZETIDINE-1-CARBONYL)PHENYL)-(HETERO-)ARYLSULFONAMIDE DERIVATIVES AS PYRUVATE KINASE M2 (PMK2) MODULATORS

IPC classification:
A61K 31/397, A61P 35/00, C07D 215/36, C07D 401/12
Applicant:
Agios Pharmaceuticals Inc
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP14872252

METHODS AND DEVICES FOR MANIPULATING SUBDERMAL FAT

IPC classification:
A61M 1/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14873761

FGFR GATEKEEPER MUTANT GENE AND DRUG TARGETING SAME

IPC classification:
A61K 31/4184, A61K 31/496, A61K 31/506, A61K 31/517, A61K 31/519, A61P 35/00, A61P 43/00
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP14874295

METHOD FOR PURIFYING ANTIBODY HAVING LOW ISOELECTRIC POINT

IPC classification:
A61K 39/395, C07K 1/18, C07K 1/20, C07K 1/22, C07K 16/00
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15187267

REFRIGERATOR AND METHOD FOR MANUFACTURING THE SAME

IPC classification:
F25C 5/00, F25D 21/04
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15187266

DEPTH-ADJUSTABLE ICE COMPARTMENT FOR REFRIGERATOR AND METHOD FOR MANUFACTURING THE SAME

IPC classification:
F25C 5/00
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15187263

ICE MAKER OF A REFRIGERATOR AND METHOD OF MANUFACTURING THE SAME

IPC classification:
F25C 1/24
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15187265

REFRIGERATOR AND METHOD FOR ASSEMBLING ICE MACHINE THEREOF

IPC classification:
F25C 1/04, F25C 1/24
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP12184423

METHODS AND SYSTEMS FOR SOLUTION BASED SEQUENCE ENRICHMENT AND ANALYSIS OF GENOMIC REGIONS

IPC classification:
C12Q 1/68
Applicant:
F. Hoffmann-La Roche AG
Applicant:
Roche Diagnostics GmbH
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
PATENT GRANTED
EP10838297

COMPOSITIONS FOR TREATING PERIPHERAL VASCULAR DISEASE

IPC classification:
A61K 31/198, A61K 31/497, A61K 31/519, A61K 45/06, A61P 9/08
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP15776419

IMMUNOACTIVATING ANTIGEN-BINDING MOLECULE

IPC classification:
A61K 39/395, A61P 35/00, A61P 43/00, C07K 16/30
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15780038

METHODS AND COMPOSITIONS FOR MODIFYING GENOMIC DNA

IPC classification:
C12N 5/10
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15793048

T CELL-REDIRECTED ANTIGEN-BINDING MOLECULE FOR CELLS HAVING IMMUNOSUPPRESSION FUNCTION

IPC classification:
A61K 39/395, A61P 15/00, A61P 35/00, A61P 35/02, C07K 16/28, C07K 16/46, C12N 15/00
Applicant:
Chugai Pharmaceutical Co., Ltd. (Chugai Seiyaku Kabushiki Kaisha)
Applicant:
Osaka University
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15187261

REFRIGERATOR HAVING LOCKING DEVICE FOR ICE BUCKET AND METHOD FOR INSTALLING LOCKING DEVICE FOR ICE BUCKET

IPC classification:
F25C 5/00, F25C 5/18, F25D 11/02
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP16002068

COMBINATION THERAPY FOR THE TREATMENT OF OCULAR NEOVASCULAR DISORDERS

IPC classification:
C12N 15/11
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
APPLICATION PUBLISHED
EP15738385

LIQUID FEEDING DEVICE FOR THE GENERATION OF DROPLETS

IPC classification:
B01D 1/18
Applicant:
Sanofi Pasteur SA
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15834988

ADMINISTRATION OF KYNURENINE DEPLETING ENZYMES FOR TUMOR THERAPY

IPC classification:
A61K 35/14, A61K 38/46, C12N 9/14
Applicant:
The Board of Regents of the University of Texas System
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15837061

SOLUBLE EPOXIDE HYDROLASE INHIBITORS AND USES THEREOF

IPC classification:
C07D 213/81
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
EXAMINATION REQUESTED
EP15839768

IDENTIFICATION AND USE OF CIRCULATING NUCLEIC ACIDS

IPC classification:
C12P 19/34, C40B 20/04, C40B 40/06
Applicant:
Stanford University - Office of The General Counsel
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15842179

PREPARATION METHOD FOR AROMATIC HETEROCYCLIC COMPOUND USED AS SELECTIVE JAK3 AND/OR JAK1 KINASE INHIBITOR AND APPLICATION OF AROMATIC HETEROCYCLIC COMPOUND

IPC classification:
A61K 31/33, A61K 31/506, A61P 19/10, A61P 35/00, C07D 239/48, C07D 405/12, C07D 413/12
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15843023

A METHOD AND APPARATUS FOR CONTINUOUSLY APPLYING NANOLAMINATE METAL COATINGS

IPC classification:
B65G 49/02, C25D 17/28, C25D 21/10
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15842607

METHODS OF PREPARING ARTICLES BY ELECTRODEPOSITION AND ADDITIVE MANUFACTURING PROCESSES

IPC classification:
B32B 15/04, C25D 5/02, C25D 21/10
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15842267

NICKEL-CHROMIUM NANOLAMINATE COATING OR CLADDING HAVING HIGH HARDNESS

IPC classification:
C25D 5/02, C25D 5/08, C25D 5/14
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15845138

COMPOSITIONS AND METHODS FOR ENHANCING HAIR GROWTH, PROMOTING SKIN REGENERATION, AND WOUND HEALING

IPC classification:
A61K 31/245, A61K 31/5575, A61P 17/02, A61P 17/14, C07C 219/22
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP16177331

COMPOSITION COMPRISING POLYSACCHARIDES EXTRACTED FROM LENTINUS, PORIA AND TREMELLA AND USE THEREOF FOR COMBATING INFLUENZA VIRUS

IPC classification:
A61K 31/715, A61P 31/16
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
The application has been published
EP15858273

DEVICES AND METHODS FOR ABLATION OF THE SKIN

IPC classification:
A61B 17/34
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15864173

PIGMENT EPITHELIUM DERIVED FACTOR (PEDF) FOR THE TREATMENT OF UTERINE FIBROIDS

IPC classification:
A61K 38/18, A61P 15/00
Applicant:
Ramot at Tel-Aviv University Ltd.
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made
EP15864857

METHODS AND COMPOSITIONS FOR TREATING MIGRAINE AND CONDITIONS ASSOCIATED WITH PAIN

IPC classification:
A61K 9/22, A61P 25/06, C07C 49/786
Agent:
Raphael Bösl, Isenbruck Bösl Hörschler LLP
Status:
Request for examination was made

Please Sign in to use this feature